potential partner

which of you knew the good James Shaw who is the deputy Glass works simultaneously in Neuren and Roche from 2015 to today ????
events that affect Shaw with Neuren are very significant and I expose them chronologically:
September 2, 2013 Neuren informs the market that on the basis of very meaningful clinical data on the company's strategy focuses on Rett and FX to translate the best results in financial terms, and facilitate future partnerships !!!!
http://www.stocknessmonster.com/news-item?S=NEU&E=ASX&N=753299
in August 2013 Shaw on his facebook profile announces new job with Neuren and the day 3 September 2014 the transfer to Melbourne.
at the end of December 2014 Neuren communicates BT proposal for Rett and January 17, 2015 Shaw announced the start of a new job with Hoffmann-La Roche.
from that moment the title performs up to 0.17 and then declined to refer to Phase 3 Rett.
from all this it can be assumed that the good James is scientific director for Neuren and Roche. easy to think of who that famous partner Treagus announces long. easy to think that Neuren asked BT to close as early as 2015 the partnership with Roche.
all my assumptions net of documents.
https://www.facebook.com/james.shaw.3114935?fref=ts